Oxidation-modified low-density lipoprotein (ox-LDL) promotes atherosclerosis through the release of CXCL1, a chemokine that is anchored to the surface of endothelial cells, facilitating monocyte adhesion and the progression of atherosclerosis. Here, CXCL1 is linked to atherosclerosis.